Zobrazeno 1 - 10
of 153
pro vyhledávání: '"Y, Becouarn"'
Autor:
Amandine Gouverneur, Juliette Coutureau, Jérémy Jové, Magali Rouyer, Angela Grelaud, Sophie Duc, Stéphane Gérard, Denis Smith, Alain Ravaud, Cécile Droz, Marie-Agnès Bernard, Régis Lassalle, Annie Forrier-Réglat, Pernelle Noize, D. Smith, N. Tubiana-Mathieu, P. Michel, R. Guimbaud, Y. Becouarn, F. Viret, D. Larregain-Fournier, Y. Botreau, P. Texereau, D. Auby, L. Gautier-Felizot, I. Loury-Larivière, E. Brudieux, L. Cany, C. Lecaille, D. Jaubert, P. Guichard, O. Bernard, L. Vives, N. Taoubi, M. Martinez, F. Burki, I. Roque, F. Thouveny, M.H. Gaspard
Publikováno v:
Clinical Colorectal Cancer
Clinical Colorectal Cancer, Elsevier, 2019, 18 (1), pp.e150-e162. ⟨10.1016/j.clcc.2018.11.005⟩
Clinical Colorectal Cancer, Elsevier, 2019, 18 (1), pp.e150-e162. ⟨10.1016/j.clcc.2018.11.005⟩
International audience; BACKGROUND: Metastatic colorectal cancer (mCRC) is increasingly treated using targeted therapies. Their real-life evaluation is insufficient, especially in elderly and frail patients. The aim was to describe use, safety, and e
Autor:
A. Jorgensen, C. Cripps, R. Mayer Steinacker, Y. Merrouche, A. Man, G. Batist, J. Schuller, M. Wirth, S. Pyrhonen, G. Vantrappen, H. Bergermann, B. Weinerman, A. Jakobsen, A. Scaletzky, J. Seitz, Jean A. Maroun, H. Ravn, J. Bury, E. Francois, D. Lutz, R. Johansson, H. Smith, C. Blaes, F. Porzsolt, B. May, E. Pannuti, M. Budde, John A. Levi, Peter Sherman, J. Skillings, R. Goel, J. Heise, M. Froimtchuk, P. Guillou, M. De Lourdes Lopes De Oliveira, W. Kocha, P. Lankisch, P. Selby, K. Bertelsen, M Namer, John Stewart, Euan Walpole, R. Mertelsmann, J. Primrose, S. Holmstrom, P. Carey, J. Mejlholm, David R. Bell, Damien Thomson, U. Ward, G. Boos, Allan Solomon Zimet, V. Fosser, R. Luykx, T. Shore, G. Massimini, Stephen P. Ackland, Michael D. Green, E. Lindegaard Madsen, J. Salomon, M. Colleoni, A. K. L. Yap, John Zalcberg, G. Cartei, M. Schupp, E. E. Holdener, M. Giovannini, R. Egeli, C. Berg, P. Rebattu, Y. Becouarn, N. Brunsgaard, L. Cockey, C. Sodomann, L. Lepoutre, M. Reginster, M. Kjaer, E. Sandberg, J. Greving, L. De Facq, S. Somers, R. Brunet, O. P. Isokangas, E. Van Cutsem, C. Gadeberg, U. Fogl, E. Bajetta, P. Rougier, V. Kataja, D. Dalley
Publikováno v:
Journal of Clinical Oncology. 13:921-928
PURPOSE To compare the efficacy and toxicity profiles of a combination of fluorouracil (5-FU) with recombinant human interferon alfa-2a (Roferon-A; Hoffman La-Roche AG, Basel, Switzerland) versus the combination of 5-FU with leucovorin (LV) in the tr
Autor:
S, Evrard, M, Rivoire, J -P, Arnaud, E, Lermite, C, Bellera, M, Fonck, Y, Becouarn, C, Lalet, M, Puildo, S, Mathoulin-Pelissier
Publikováno v:
The British journal of surgery. 99(4)
Publikováno v:
Bulletin du cancer.
After decades of exclusive use of fluorouracil in the treatment of metastatic colorectal cancer, three new drugs, among them oxaliplatin, have recently shown interesting results. Oxaliplatin has an activity when it is given alone but this drug is par
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Bulletin du cancer. 86(2)
New innovative cytotoxic agents have proven active for treating patients with metastatic cancer who have failed first line 5FU based therapy, with sizeable objective response rates and a much higher rate of stabilization. The benefit of stabilization
Autor:
Y, Becouarn, P, Rougier
Publikováno v:
Seminars in oncology. 25(2 Suppl 5)
For the past 40 years, the mainstay of chemotherapy against colorectal cancer has been 5-fluorouracil (5-FU), often administered in recent years with folinic acid modulation. Traditional platinum derivatives have generally been ineffective in colorec
Publikováno v:
Revue neurologique. 149(4)
A 45 year-old patient presented with an epidermoid carcinoma of the tongue and cranial hypertension. MRI showed dural venous sinus occlusion, without infiltration or compression by a metastatic tumor. Anticoagulation led to recanalization of the occl
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
A S, Allal, J M, Dilhuydy, P, Lagarde, D, Stoll, M, Benhaddou, P, Richaud, L, Traissac, Y, Becouarn, A, Faucher
Publikováno v:
Annales de radiologie. 34(4)
From april 1978 to december 1988, 24 patients were treated were by radiotherapy at the Bergonié Foundation cases were for ethmoidal cancer cases. Twenty two for initial treatment and two refermed for local recurrence. The mean age was 51.4 years and